Novavax, Inc.
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionProfund Advisors Llc
Latest Disclosed Ownership110,955 shares
Latest Disclosed Value $ 903,174
Profund Advisors Llc reports 8.82% decrease in ownership of NVAX / Novavax, Inc.

On April 24, 2026 - Profund Advisors Llc filed a 13F-HR form disclosing ownership of 110,955 shares of Novavax, Inc. (MX:NVAX) valued at $903,174 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 121,693 shares of Novavax, Inc.. This represents a change in shares of -8.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVAVAX COM NEW 670002401 110,955 -10,738 -8.82 903 10.53 0.0332
2026-02-06 2025-12-31 13F NOVAVAX COM NEW 670002401 121,693 65,631 117.07 818 68.11 0.0248
2025-11-06 2025-09-30 13F NOVAVAX COM NEW 670002401 56,062 2,769 5.20 486 45.07 0.0158
2025-08-07 2025-06-30 13F NOVAVAX COM NEW 670002401 53,293 -4,543 -7.85 336 -9.46 0.0121
2025-05-08 2025-03-31 13F NOVAVAX COM NEW 670002401 57,836 -11,377 -16.44 371 -33.45 0.0161
2025-02-14 2024-12-31 13F NOVAVAX COM NEW 670002401 69,213 -4,755 -6.43 556 -40.47 0.0203
2024-11-14 2024-09-30 13F NOVAVAX COM NEW 670002401 73,968 24,655 50.00 934 49.68 0.0353
2024-08-13 2024-06-30 13F NOVAVAX COM NEW 670002401 49,313 -207,745 -80.82 624 -49.19 0.0232
2024-05-08 2024-03-31 13F NOVAVAX COM NEW 670002401 257,058 407 0.16 1,229 -0.24 0.0478
2024-02-14 2023-12-31 13F NOVAVAX COM NEW 670002401 256,651 91,857 55.74 1,232 3.19 0.0529
2023-11-13 2023-09-30 13F NOVAVAX COM NEW 670002401 164,794 -34,389 -17.27 1,193 -19.34 0.0660
2023-08-10 2023-06-30 13F NOVAVAX COM NEW 670002401 199,183 9,542 5.03 1,480 12.56 0.0794
2023-05-12 2023-03-31 13F NOVAVAX COM NEW 670002401 189,641 189,641 1,314 0.0812
2022-11-04 2022-09-30 13F NOVAVAX COM NEW 670002401 0 -8,928 -100.00 0 -100.00
2022-08-01 2022-06-30 13F NOVAVAX COM NEW 670002401 8,928 -491 -5.21 459 -33.86 0.0291
2022-05-10 2022-03-31 13F NOVAVAX COM NEW 670002401 9,419 -977 -9.40 694 -53.33 0.0291
2022-02-08 2021-12-31 13F NOVAVAX COM NEW 670002401 10,396 -1,682 -13.93 1,487 -40.62 0.0486
2021-11-12 2021-09-30 13F NOVAVAX COM NEW 670002401 12,078 444 3.82 2,504 1.38 0.0844
2021-08-12 2021-06-30 13F NOVAVAX COM NEW 670002401 11,634 -2,220 -16.02 2,470 -1.67 0.0830
2021-05-14 2021-03-31 13F NOVAVAX COM NEW 670002401 13,854 607 4.58 2,512 70.07 0.0966
2021-02-09 2020-12-31 13F NOVAVAX COM NEW 670002401 13,247 1,671 14.44 1,477 17.78 0.0645
2020-11-13 2020-09-30 13F NOVAVAX COM NEW 670002401 11,576 11,576 1,254 0.0645
2019-05-15 2019-03-31 13F NOVAVAX COM 670002104 0 -11,214 -100.00 0 -100.00
2019-02-14 2018-12-31 13F NOVAVAX COM 670002104 11,214 -4,347 -27.94 21 -27.59 0.0013
2018-11-13 2018-09-30 13F NOVAVAX COM 670002104 15,561 0 0.00 29 38.10 0.0011
2018-08-13 2018-06-30 13F NOVAVAX COM 670002104 15,561 162 1.05 21 -34.37 0.0008
2018-05-14 2018-03-31 13F NOVAVAX COM 670002104 15,399 0 0.00 32 68.42 0.0013
2018-02-14 2017-12-31 13F NOVAVAX COM 670002104 15,399 2,065 15.49 19 26.67 0.0007
2017-11-13 2017-09-30 13F NOVAVAX COM 670002104 13,334 -107,441 -88.96 15 -89.21 0.0006
2017-08-11 2017-06-30 13F NOVAVAX COM 670002104 120,775 455 0.38 139 -9.74 0.0063
2017-04-25 2017-03-31 13F NOVAVAX COM 670002104 120,320 -10,371 -7.94 154 -6.67 0.0069
2017-02-13 2016-12-31 13F NOVAVAX COM 670002104 130,691 -17,752 -11.96 165 -46.60 0.0076
2016-11-10 2016-09-30 13F NOVAVAX COM 670002104 148,443 -4,493 -2.94 309 -72.21 0.0147
2016-08-12 2016-06-30 13F NOVAVAX COM 670002104 152,936 -6,470 -4.06 1,112 35.12 0.0541
2016-05-06 2016-03-31 13F NOVAVAX COM 670002104 159,406 -37,354 -18.98 823 -50.15 0.0427
2016-02-05 2015-12-31 13F NOVAVAX COM 670002104 196,760 -397 -0.20 1,651 18.44 0.0783
2015-11-06 2015-09-30 13F NOVAVAX COM 670002104 197,157 197,157 0.00 1,394 0.0794
2014-11-06 2014-09-30 13F NOVAVAX COM 670002104 0 -17,205 -100.00 0 -100.00
2014-08-08 2014-06-30 13F NOVAVAX COM 670002104 17,205 1,005 6.20 79 8.22 0.0035
2014-05-07 2014-03-31 13F NOVAVAX COM 670002104 16,200 16,200 73 0.0033
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.